In short. A clot spun from the patient's own blood, injected as a material rather than supplied as a licensed product, and reabsorbed after a short period.
Key points
- That a preparation forms a fibrin network is a statement about composition.
- That the network improves skin, restores volume or rebuilds tissue is a statement about an outcome.
- The first is established and the second is claimed, and the distance between them is where this subject is argued about.
Platelet-rich fibrin is a material made from a person’s own blood and injected into their face. Understanding what it is made of, and what kind of object it is, explains most of what follows.
A preparation rather than a product
Blood is drawn, spun so that the platelets and the fibrin concentrate into a layer, and the resulting preparation is taken up and injected in the same session. It is not a manufactured substance with a batch number, a defined composition and a set of release tests. It is a biologic prepared at the point of care, and that distinction is not a technicality: it determines what can be known about it, what can be standardised about it and what a person is actually consenting to when they agree to it.
The fibrin network
The preparation coagulates into a fibrin network without an added anticoagulant, which is the material difference between this and the earlier generation of platelet concentrates. It is a real property and it is well described. Whether that network does anything useful once it is in tissue is a separate question, and the honest answer at present is that the structure exists and what follows from it is not established.
A material property is not an effect
That a preparation forms a fibrin network is a statement about composition. That the network improves skin, restores volume or rebuilds tissue is a statement about an outcome. The first is established and the second is claimed, and the distance between them is where this subject is argued about.
It is reabsorbed
The preparation does not remain in the tissue as a filler does. It is broken down and cleared over a short period, which means the volume it provides is temporary and any effect that persists has to be explained by something other than the presence of the material. This is worth understanding before a treatment rather than after, because a person who expects a lasting change in shape has misunderstood what is being injected.
What it is not
It is not a licensed product, so it has no approved indication. It is not a filler, so it does not restore volume in the way a defined material does. It is not standardised, so two clinics offering it are not necessarily offering the same substance. And it is not risk-free, even though the material comes from the person receiving it, because removing the risk of donor transmission does not remove the risk of what happens during preparation.
Three questions worth asking about the material
- How is the preparation made here, and how long passes between drawing the blood and injecting it?
- Is anything added to it, or is it used as it comes from the spin?
- What is it expected to do that another treatment would not, and on what evidence is that expectation based?
Answering those three turns a name into a description of a specific process, which is the only form in which the treatment can be weighed.
Frequently asked questions
What is platelet-rich fibrin made of?
Blood drawn from the person receiving it, spun so that the platelets and the fibrin concentrate, and used in the same session. The preparation coagulates into a fibrin network, and it is injected as a material rather than applied to the skin.
How is it different from an earlier platelet concentrate?
The difference is in the preparation. An earlier concentrate is separated with an added anticoagulant and then activated, while this preparation coagulates without one and forms a fibrin network as it does. It is a genuine difference in the material and it does not by itself establish anything about the effect.
Is it a product with an approval?
No. It has no product authorisation and no approved indication, because there is no manufactured product to authorise. What is injected is made in the room, from the person in it, shortly before it is used, and the devices involved are regulated as laboratory equipment rather than as a medicine.
Risks & Limitations
- The preparation is made in the room and is not standardised, so two clinics offering the same named treatment are not necessarily offering the same material.
- Blood handled outside a controlled laboratory is a medium in which bacteria grow, so preparation carries a risk of infection that the source of the blood does not remove.
- The material is reabsorbed over a short period, so it does not restore volume the way a filler does.
- There is no product authorisation and no approved indication, because there is no manufactured product to authorise.
- Growth factors measured in laboratory work are a finding about the material and not a demonstrated clinical result.
When to Seek Care
- Redness, warmth, swelling or pain that is increasing rather than settling after an injection.
- Discharge from an injection site, or a fever — seek prompt clinical assessment.
- An uneven or lumpy result, or any change in the treated area that concerns you.
- Contact the service that performed the treatment, or the hospital’s outpatient channels, rather than relying on a website.
References & Further Reading
- U.S. Food and Drug Administration (FDA) — guidance on autologous cellular products and point-of-care preparation
- European Medicines Agency (EMA) and national regulators — guidance on blood-derived and autologous treatments
- National Medical Products Administration (NMPA, China) — regulation of blood-derived preparations and devices
- World Health Organization (WHO) — guidance on the safe preparation and handling of blood components
- Cochrane Library — systematic reviews of platelet concentrates for skin and wound indications
This page is patient education, not medical advice, and it does not cite individual studies. It reviews evidence and regulation; it is not a booking page and does not recommend a treatment. Discuss your own case with a qualified clinician. To ask a question about this review, see Contact & Consultation.